Press release
Peptide Based Cardiovascular Therapeutics Market Estimated to Reach US$ 1,960 Mn by 2022
Request For Sample Report @ www.factmr.com/connectus/sample?flag=S&rep_id=191
Increasing healthcare expenditure and increasing FDI in emerging economies along with the emergence of prominent pharmaceutical and biotech companies is fuelling market growth in peptide therapeutics. Besides, growing number of people suffering from cardiovascular diseases is also fuelling the market for peptide therapeutics. Breakthroughs in the development of therapeutic peptides for treating cardiovascular diseases and the development of new peptides is also fuelling the market growth. However, various factors such as increasing cost of developing peptides, rapid metabolism of peptide drugs and a stringent regulatory framework may restrain the growth of therapeutic peptides.
The global peptide based cardiovascular therapeutics market is slated to touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
4 Forecast Highlights on Global Peptide Based Cardiovascular Therapeutics Market
As per the forecast of Fact.MR, the eptifibatide segment is slated to touch a value of nearly US$ 600 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The eptifibatide segment is estimated to account for nearly one-third of the revenue share of the drug segment by the year 2017 end and is expected to gain in market share by the year 2022 end.
Check Discount @ www.factmr.com/connectus/sample?flag=D&rep_id=191
As per the forecast of Fact.MR, the retail pharmacies segment will reach a value of nearly US$ 425 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The retail pharmacies segment is estimated to account for more than one-third of the revenue share of the distribution channel segment in the year 2017 end and is expected to gain market share by the end of the year 2022.
As per the forecast of Fact.MR, North America peptide based cardiovascular therapeutics market is expected to register a robust CAGR over the forecast period and to be valued at nearly US$ 830 Mn by 2022 end.
As perFact.MR forecasts, US peptide based cardiovascular therapeutics market is estimated to account for 88.6% revenue share of the global peptide based cardiovascular therapeutics market by 2017 end and is expected to gain market share by 2022 over 2017
The report has also profiled leading players in the global market for peptide based cardiovascular therapeutics, which will remain active through 2022. These include companies such as Amneal Pharmaceuticals LLC, Fresenius Kabi USA, LLC, Corden Pharma GmbH, AstraZeneca, plc, Novetide Ltd, Pfizer Inc, Dr. Reddy’s Laboratories Limited, Ipsen S.A, Apotex Holdings, Inc. and Merck & Co.
Click to View Complete Report @ https://www.factmr.com/report/191/peptide-based-cardiovascular-therapeutics-market
About Us
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
Office: Dublin 2
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-6111-593
( Dublin 2 )
Email: sales@factmr.com
Web: https://www.factmr.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Cardiovascular Therapeutics Market Estimated to Reach US$ 1,960 Mn by 2022 here
News-ID: 711921 • Views: …
More Releases from Fact.MR
Insights into the Medical Gloves Market to Exceed US$ 27 Billion by 2034
The global medical gloves market (医療用手袋市場) is projected to reach a valuation of over US$ 27,141.5 million by 2034, growing from an estimated worth of US$ 11,299 million in 2024, with a forecasted compound annual growth rate (CAGR) of 9.2% until 2034.
The increasing emphasis on hygiene and infection control, particularly in healthcare environments, is driving demand for medical gloves. This demand is further fueled by stringent regulations governing healthcare standards.…
Aerial Inspection Services Market is accelerate at a CAGR of 17.5% to top US$ 9. …
The global Aerial Inspection Services is expected to reach a value of US$ 1.9 billion and is projected to grow at a compound annual growth rate (CAGR) of 17.5% over the next decade, reaching US$ 9.5 billion by 2033.Drone inspection services dominate this market, accounting for approximately 90.0% of the total aerial inspection services sector. Moreover, this segment represents a significant portion, around 25.0%, of the broader drone services market,…
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
In 2024, the global bioink market (バイオインク市場) is estimated at US$ 185.6 million. Forecasts project a remarkable Compound Annual Growth Rate (CAGR) of 18.8%, catapulting the demand for bioinks to reach a substantial market value of US$ 1.03 billion by 2034.
Recent years have witnessed a consistent rise in the necessity for organ replacements and tissue regeneration. Innovations in these fields are anticipated to facilitate the transformation of damaged tissues into…
Bonded Magnet Market is forecast to reach a valuation of US$ 10.9 Billion by 203 …
The Bonded Magnet Market is currently valued at around US$ 5.1 billion, and it is expected to experience substantial growth in the coming years. Projections suggest that the market will reach a valuation of US$ 10.9 billion by 2032, growing at an impressive compound annual growth rate (CAGR) of 7.8% from 2022 to 2032.
Bonded magnets play a significant role in the global magnet market, accounting for approximately 14% of its…
More Releases for Therapeutic
HOME THERAPEUTIC EQUIPMENT INDUSTRY OUTLOOK 2022
The global home therapeutic equipment market is projected to grow from USD 11.06 billion in 2018 to USD XX.XX billion by 2030, at a CAGR of 5.5% during the forecast period. The growth of this market can be attributed to the increasing prevalence of chronic diseases, the rising geriatric population, and the growing demand for home healthcare services.
Get free copy of the report 2022: https://www.accuracyreports.com/request/download/12/11431/Global-Home-Therapeutic-Equipment-Industry-Outlook-2022:-Overview-Opportunities-Key-Companies-and-Forecast-to-2028
This report studies the Home Therapeutic…
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies…
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION
The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system…
Therapeutic Vaccines Market Insights by Top Players Novartis AG, GlaxoSmithKline …
Vaccine is a biological product that initiates stimulation to antibodies and helps provide immunity against infectious and chronic diseases. There are various types of vaccines such as inactivated vaccines, subunit vaccines, recombinant vector vaccines and DNA vaccines. Vaccines are mainly prophylactic in nature along with therapeutic effect. The wide application of vaccines is expected to favor the therapeutic vaccines market. Therapeutic vaccine is a combination of biologics that is designed…
Therapeutic Socks Market
Therapeutic Socks Market Overview
Compression therapy is a safe and cost-effective method of treating wounds, vein thrombosis, phlebitis and providing post-surgery care. It relies on a simple yet efficient principle – applying an elastic garment around a limb. A relatively new form of treatment, it is anticipated to post rapid growth during the next decade. Compression therapy includes garments like leggings, shirts, socks and stockings. The therapeutic socks market, otherwise known…
